This series examines the UPMC Enterprises portfolio companies and technology solutions continuing to serve both patients and providers during the COVID-19 pandemic. Check out previous entries here.
The COVID-19 pandemic has tested the resources and facilities of health systems around the globe. With social distancing encouraged, providers and patients who were once reluctant to try telemedicine are discovering the convenience of the technology.
Infectious Disease Connect (ID Connect), an Enterprises spin-out company delivering infectious disease expertise via telemedicine, is aiding strained hospitals with stepped up consultation services.
The company, which was created in the spring of 2019 as a response to the national shortage of infectious disease specialists, is supporting its customers with full levels of service. ID Connect’s specialists also are meeting an emergent, immediate need by providing ID-specific and infection prevention and control telephonic consultations to as many additional hospitals as possible.
As COVID-19 continues to strain hospital resources and staff, ID Connect recently established a 24/7 call center to provide ID expertise whenever needed.
The national shortage of ID specialists has created difficulty for many community and rural hospitals and health care facilities in recruiting and retaining physicians with ID expertise. In addition, many hospitals don’t have the need for a full-time ID specialist. ID Connect fills this gap by providing these facilities with world-class, academic ID expertise through an end-to-end telemedicine solution.
“ID Connect team is steadfast in their commitment to providing the best telemedicine solution within the constraints of the current pandemic climate and is working diligently to do their part in combating COVID-19,” said David Zynn, CEO of ID Connect.
